| Identification | Back Directory | [Name]
4-butyl-1-phenylpyrazolidine-3,5-dione, sodium salt | [CAS]
41468-34-2 | [Synonyms]
BRN0213056
BRN-0213056
BRN 0213056
Einecs 255-384-4
Mofebutazone sodium
4-butyl-1-phenylpyrazolidine-3,5-dione, sodium salt | [EINECS(EC#)]
255-384-4 | [Molecular Formula]
C13H15N2NaO2 | [MOL File]
41468-34-2.mol | [Molecular Weight]
254.26 |
| Hazard Information | Back Directory | [Uses]
Mofebutazone sodium is the monophenyl analog of phenylbutazone (DPB), an anti-inflammatory compound. Mofebutazone sodium is used in asthma research[1][2]. | [References]
[1] F.T. Delbeke, et al. Determination of mofebutazone and its 4-hydroxy metabolite in plasma and urine by high-performance liquid chromatography. Journal of Chromatography A. Volume 369, 1986, Pages 440-444.
[2] Khayyal MT,et al. Tolerability of mofebutazone in asthmatic patients. Int J Clin Pharmacol Res. 1995;15(4):145-51. PMID:8871264 |
|
|